Zhenkun Fu

Guangxi University — China

Medicine · Health Sciences

18h-index806citations47works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(10), Immunotherapy and Immune Responses(7), Immune Cell Function and Interaction(7), T-cell and B-cell Immunology(6), Cancer-related Molecular Pathways(4)

Publications47 total

Targeting “don’t eat me” signal: breast cancer immunotherapy
Breast Cancer Research and Treatment·2025
Exosome coated with Prussian blue mediated microglial polarization for spinal cord injury
Materials & Design·2025· 2 citedOpen Access
Na+/K+-ATPase: a multifunctional target in type 2 diabetes and pancreatic islets
Frontiers in Immunology·2025Open Access
Effects of Freezing and Radio Frequency Tempering on Quality Characteristics of Marinated Yellow-Fin Tuna (Thunnus Albacares)
Food and Bioprocess Technology·2024· 3 cited
<scp>MCL</scp> restrained <scp>ROS/AKT/ASAH1</scp> pathway to therapy tamoxifen resistance breast cancer by stabilizing <scp>NRF2</scp>
Cell Proliferation·2024· 6 citedOpen Access
Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Biochemistry and Biophysics Reports·2024· 4 citedOpen Access
Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review
Medicine·2024· 11 citedOpen Access
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression
Cellular and Molecular Life Sciences·2023· 26 citedOpen Access
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Journal of Cancer Research and Clinical Oncology·2023· 8 citedOpen Access
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
Cell Death and Disease·2022· 11 citedOpen Access
Targeting estrogen-mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer
Research Square (Research Square)·2022· 1 citedOpen Access
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma
Research Square (Research Square)·2022Open Access
Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review
Medicine·2022· 13 citedOpen Access
Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences·2022· 20 citedOpen Access
Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
Cells·2022· 5 citedOpen Access
Targeting glucose‐6‐phosphate dehydrogenase by <scp>6‐AN</scp> induces <scp>ROS</scp> ‐mediated autophagic cell death in breast cancer
FEBS Journal·2022· 38 citedOpen Access
Author response for "Targeting glucose‐6‐phosphate dehydrogenase by &lt;scp&gt;6‐AN&lt;/scp&gt; induces &lt;scp&gt;ROS&lt;/scp&gt; ‐mediated autophagic cell death in breast cancer"
2022
Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery
Frontiers in Oncology·2022· 18 citedOpen Access
Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility
Oncotarget·2017· 24 citedOpen Access
Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer
Oncotarget·2016· 11 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Dianjun Li(24), Da Pang(16), Fengyan Xu(14), Dalin Li(13), Weiguang Yuan(13), Zhoujun Lin(13), Shuang Chen(9), Xiao Han(9), Xiaolin Pei(8), Tianjiao Li(8), Chenggang Li(8), Dalin Li(6), Ya Feng(6), Changjun Wang(6), Lizhong Yan(5), Yupeng Zhang(4), Mao Yang(4), Chenggang Li(4), Lihong Wang(3), Shaoli Han(3)